Ulf Holmgren
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study.
Journal: International journal of chronic obstructive pulmonary disease
Published: July 04, 2022
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.
Journal: Respiratory research
Published: March 02, 2022
The long-term clinical impact of COPD exacerbations: a 3-year observational study (SHERLOCK).
Journal: Therapeutic advances in respiratory disease
Published: February 14, 2022
Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States.
Journal: Therapeutic advances in respiratory disease
Published: April 19, 2021
Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.
Journal: Advances in therapy
Published: January 22, 2021
A Systematic Literature Review of the Humanistic Burden of COPD.
Journal: International journal of chronic obstructive pulmonary disease
Published: December 15, 2020
Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK.
Journal: International journal of chronic obstructive pulmonary disease
Published: August 21, 2020
Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease.
Journal: Pulmonary therapy
Published: June 24, 2020
Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.
Journal: Advances in therapy
Published: February 10, 2020
Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.
Journal: International journal of chronic obstructive pulmonary disease
Published: March 29, 2018
Last Updated: 09/26/2026